Skip to main content

Table 2 Clinical and biochemical characteristics according to the presence of metabolic syndrome

From: Usefulness of metabolic syndrome score in the prediction of angiographic coronary artery disease severity according to the presence of diabetes mellitus: relation with inflammatory markers and adipokines

Parameters

Without MS (N = 185)

With MS (N = 178)

p value

Age (years)

61.8 ± 11.5

62.2 ± 10.6

0.728

Male

100 (54%)

96 (54%)

0.981

BMI (kg/m2)

23.7 ± 2.8

26.0 ± 2.8

<0.001

Waist circumference (cm)

85.9 ± 8.6

92.9 ± 9.2

<0.001

Hip circumference (cm)

91.2 ± 8.2

95.2 ± 7.0

<0.001

Waist-hip ratio

0.94 ± 0.07

0.97 ± 0.11

0.064

Systolic BP (mmHg)

122.9 ± 17.4

127.2 ± 20.2

0.028

Diastolic BP (mmHg)

74.2 ± 10.4

75.7 ± 12.0

0.189

Smoking

28 (15%)

22 (12%)

0.443

Hypertension

74 (40%)

155 (87%)

<0.001

Diabetes

17 (9%)

70 (39%)

<0.001

Total cholesterol (mg/dL)

161.3 ± 35.2

153.3 ± 41.8

0.050

TG (mg/dL)

97.8 ± 37.3

158.5 ± 78.2

<0.001

HDL-C (mg/dL)

48.4 ± 11.9

39.6 ± 8.5

<0.001

LDL-C (mg/dL)

101.7 ± 34.4

97.6 ± 30.9

0.245

Lipoprotein(a) (mg/dL)

22.4 ± 28.5

18.9 ± 21.5

0.196

FBG (mg/dL)

96.1 ± 18.0

106.6 ± 25.6

<0.001

Serum insulin (μIU/mL)

5.5 ± 4.9

9.4 ± 13.3

<0.001

HOMA-IR*

1.4 ± 1.7

2.5 ± 3.5

<0.001

hs-CRP (mg/L)

5.4 ± 13.7

6.1 ± 17.3

0.716

IL-6 (pg/mL)

2.3 ± 3.7

3.0 ± 5.0

0.103

Resistin (ng/mL)

5.8 ± 3.8

7.1 ± 7.0

0.036

Adiponectin (μg/mL)

7.5 ± 5.7

5.8 ± 4.7

0.002

  1. MS = metabolic syndrome; BMI = body mass index; BP = blood pressure; TG = triglyceride; HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol; FBG = fasting blood glucose; HOMA-IR = the homeostatic model assessment of insulin resistance; hs-CRP = high sensitivity C-reactive protein; IL-6 = interleukin-6.
  2. *HOMA-IR was calculated only for non-diabetic patients (n = 276).